Financial plays

Top 5 snaps from the show: Healthy Beverage and World Tea Expos

LONG BEACH CONVENTION CENTER, CALIFORNIA (MAY 29-31)

Top 5 snaps from the show: Healthy Beverage and World Tea Expos

By Ben BOUCKLEY

Join us on a whirlwind tour of the Healthy Beverage and World Tea Expos, as we train our lens on five rising beverage brands addressing need states from enhanced hydration to digestive health.

Energy drinks with beauty benefits: A growth industry, according to MyDrink Beverages (Photo: Soren Rajczyk/Flickr)

CLEVER MARKETING CAN OVERCOME DIFFICULT EFSA SITUATION

Beauty meets the EU energy drinks beast…

By Ben BOUCKLEY

Energy drinks that also offer beauty or weight loss benefits have a growing market in the EU despite a difficult health claims environment.

Palm oil firm says sustainability not so focal for supplements

DISPATCHES FROM VITAFOODS Europe 2014

Sustainability? Not so focal for supplements, says palm oil firm

By Annie Harrison-Dunn

Sustainability is not such an important issue for the supplements industry, because of the relatively low ingredient volumes involved and a difference in industry priorities, Malaysia-based Carotech has said.

Retail positioning could bust sports nutrition segment out of negative image, according to analyst.

Retail positioning sports nutrition's big challenge

By Annie Harrison-Dunn

Establishing broad acceptance is the greatest challenge facing the sports nutrition segment today, and this hinges on the creation of local mainstream retail channels, according to one analyst. 

The doors to new applications have been reopened, but there may still be delays, says the resource-strapped Food Standards Agency

UK FSA: "We are working to clear the backlog as quickly as possible."

UK FSA reopens novel foods doors after industry concern

By Annie Harrison-Dunn

The UK Food Standards Agency (FSA) has backtracked on a decision to close its doors on EU novel foods applications after stakeholder unrest at the UK government austerity driven measure. 

Public policy expert says FSA freeze on new novel food ingredient applications is “an appalling development” that is bad for British business.

UK FSA: "If you are interested in submitting a novel food dossier to the EU, we advise you to contact another EU member state..."

UK FSA closes door on novel food applications as austerity bites

By Annie Harrison-Dunn

The UK Food Standards Agency is no longer accepting novel food applications, a development one public policy expert says is “alarming”.

Health claims are being lost in language and cultural translation, warns an EU food law advisor

Lost in translation: Parlez-vous health claims?

By Annie Harrison-Dunn

Cross-border communication must be provided to combat the confusion caused by the 24 subtly different language versions of EU-approved health claims, as well as countless other cultural nuances, according to an EU food law expert. 

“Commercialisation is not at stake,” says Sanofi following its EFSA claim disappointment

Sanofi to contest rebuffed sterol cholesterol claim, but it's no big deal

By Annie-Rose Harrison-Dunn

Sanofi-Aventis has said the European Food Safety Authority’s (EFSA) rejection of its application to broaden the already approved sterol-stanols cholesterol lowering claim to powdered supplements won’t affect the company commercially, but they will be...

Raisio grows earnings by 14%

Raisio grows earnings by 14%

Plant-based nutrition firm Raisio has reported record earnings before interest and taxes (EBIT) of almost €40m in 2013.

Symrise bids for Swedish probiotic player

Symrise bids for Swedish probiotic player

By Shane Starling

Symrise has given Swedish probiotic player, Probi’s board and shareholder’s about a month to sell it the remaining 70% it doesn’t own after making a formal bid today.

Local sporting cultures influence consumer preferences across the global protein and non-protein markets, says Euromonitor

Infographic

Protein still sports nutrition king, but watch out

By Annie-Rose Harrison-Dunn

Protein is still the bedrock of sports nutrition says Euromonitor, but non-protein products are expected to grow faster in several important global markets like Australia, Canada and Indonesia.

Belgian appeals court dismisses previous suit against Herbalife

Court overturns Herbalife pyramid case

By Annie-Rose Harrison-Dunn

Supplements giant Herbalife has won an appeal against a verdict back in 2011 which tarred the firm's recruitment and selling structure as a pyramid scheme. 

DSM OatWell FiE

Dispatches from #FIE2013

A year of change for DSM’s OatWell

By Staff Writer

One year on from its acquisition of Swedish beta-glucan brand OatWell, DSM talks about entering into new markets and capitalizing on European health claims.

Fructose firm says it is expecting big sales boom in January when EFSA health claims kick in

Sweet sales future for fructose products?

By Annie-Rose Harrison-Dunn

EFSA backing of a blood glucose lowering health claim for fructose products spells good business prospects, Israeli supplier of the ingredient Galam Group has said.

Euromonitor analyst looks at what the future of the energy supplement market looks like beyond caffeine

Beyond caffeine: Alternative energy boosters

By Annie-Rose Harrison-Dunn

As consumer perceptions of caffeine shift and the threat of more market regulation looms, companies are scrambling to find the next blockbuster to cater to demand for energy-boosting products, says an analyst.

Fytexia targets US expansion with new US-structure and Med Diet science

Fytexia targets US expansion with new US-structure and Med Diet science

By Stephen Daniells

French raw material supplier Fytexia wants to more than double its US business within five years by bringing the benefits of the Mediterranean Diet to North America, as it opens a sales office in the New York City area and a warehouse in Salt Lake City,...

New firm Burr and Burr spends £35m on two omega-3 acquisitions

New firm seals deal on £35m omega-3 acquisitions

By Annie-Rose Harrison-Dunn

New London based supplement firm Burr and Burr has announced the completion of two brand acquisitions totalling £35m within the omega-3 health supplement sector.

Tate & Lyle's long-term story remained 'compelling', said Investec analyst Martin Deboo. Corn is one of the manufacturer's main ingredients

Tate & Lyle ‘compelling’ despite price: City

By Mike Stones

Tate & Lyle’s prospects remain encouraging despite the poor share price, news revealed today (October 4) in its trading update for the six months to September 30, says City analyst Investec.

“Lucozade and Ribena are iconic brands that have made a huge contribution to GSK over the years, but now is the right time to sell them...

SOLD! GSK exits drinks market

Glaxo sells Lucozade and Ribena to Suntory for £1.35bn cash

By Shane STARLING

Ever-expanding Japanese beverage behemoth, Suntory, is the new owner of Lucozade and Ribena, which GlaxoSmithKline (GSK) has sold for £1.35bn (€1.6bn/$2.11bn) as it admits defeat in its internationalisation plans and trains its focus on its pharma activities.

Arla delivered capacity cost savings of £57M on an annual basis

Arla profits boom as mergers bear fruit

By Rod Addy

Dairy giant Arla has doubled profits for the first half of its financial year, amid news the two mergers it undertook in 2012 were paying off.

Follow us

Products

View more

Webinars